A5102714843- Cardiac Valve Diseases and Treatments
- Coronary Interventions and Diagnostics
- Cardiac Imaging and Diagnostics
- Mechanical Circulatory Support Devices
- Cardiac, Anesthesia and Surgical Outcomes
- Infective Endocarditis Diagnosis and Management
- Cardiac pacing and defibrillation studies
- Cerebrovascular and Carotid Artery Diseases
- Cardiac Structural Anomalies and Repair
- Heart Failure Treatment and Management
- Acute Myocardial Infarction Research
- Cardiovascular Function and Risk Factors
- Peripheral Artery Disease Management
- Cardiac Arrest and Resuscitation
- Pediatric Urology and Nephrology Studies
- Antiplatelet Therapy and Cardiovascular Diseases
- Health and Medical Research Impacts
- Innovation Policy and R&D
- Neonatal Health and Biochemistry
- Peripheral Nerve Disorders
- Advanced Electron Microscopy Techniques and Applications
- Radiopharmaceutical Chemistry and Applications
- Radiology practices and education
- Hip disorders and treatments
- Palliative Care and End-of-Life Issues
The University of Texas Southwestern Medical Center
2024
Cardiovascular Research Foundation
2023-2024
Georgetown University
2020-2023
University at Buffalo, State University of New York
2023
MedStar Georgetown University Hospital
2023
MedStar Washington Hospital Center
2023
Alaska Heart and Vascular Institute
2021
Emory University
2016-2018
Valve (United States)
2017
Emory and Henry College
2017
Background: Little is known about clinical characteristics, hospital course, and longitudinal outcomes of patients with cardiogenic shock (CS) related to heart failure (HF-CS) compared acute myocardial infarction (AMI; CS AMI [AMI-CS]). Methods: We examined in-hospital 1-year 520 (219 AMI-CS, 301 HF-CS) consecutive (January 3, 2017–December 31, 2019) in a single-center registry. Results: Mean age was 61.5±13.5 years, 71% were male, 22% Black patients, 63% had chronic kidney disease. The...
Background Treatment for patients with end‐stage renal disease (ESRD) and severe aortic stenosis (AS) includes balloon valvuloplasty (BAV), surgical (SAVR), or transcatheter (TAVR) valve replacement. We compared outcomes among these strategies. Methods A retrospective review of ESRD undergoing treatment AS between 07/2007 06/2015 was performed at our center. Patients were classified based on treatment: BAV‐only, TAVR, SAVR. Baseline characteristics 30‐day groups. 1‐year survival analysis...
Prior studies have found that patients with chronic kidney disease (CKD) worse outcomes following percutaneous coronary intervention (PCI). There are no data about advanced CKD undergoing Impella-supported high-risk PCI. We, therefore, aimed to evaluate angiographic characteristics and clinical in who received PCI as part of the catheter-based ventricular assist device PROTECT III study (A Prospective, Multi-Center, Randomized Controlled Trial IMPELLA RECOVER LP 2.5 System Versus Intra...
Abstract Background Asymptomatic, isolated cases of unilateral pulmonary artery atresia may present in adulthood with symptoms such as recurrent respiratory infections, dyspnea, hemoptysis, and hypertension. Unlike previously reported patients that underwent surgical management for this pathology, the patient report had no chronic history or hypertension, making a diagnosis prior to extensive imaging difficult. Case presentation A 55-year-old male presented our emergency department (ED)...
Diagnostic certainty in determining the severity of aortic stenosis (AS) can be challenging patients with low-gradient AS. Current guidelines define categories according to mean gradient (MG), left ventricular ejection fraction (LVEF), and stroke volume index (SVi). Low flow low (LFLG) is defined as valve area (AVA) < 1.0 cm2, MG 40 mm Hg, SVi 35 mL/m2.1Falk V. Baumgartner H. Bax J.J. De Bonis M. Hamm C. Holm P.J. et al.Corrigendum "2017 ESC/EACTS for management valvular heart disease.Eur J...
<h3>Introduction/Purpose</h3> Symptomatic intracranial atherosclerotic disease (ICAD) remains an important cause of recurrent stroke and acute ischemic event. Although the high periprocedural risk stenting from recent randomized studies has dampened enthusiasm for such interventions, submaximal angioplasty without may represent a safer endovascular treatment option. We aimed to investigate safety comparative efficacy performing alone vs. angioplasty. <h3>Materials Methods</h3> A...
Left ventricular (LV) systolic dysfunction worsens outcomes in patients undergoing percutaneous coronary intervention (PCI). The objective of this study, therefore, was to evaluate pLVAD-supported high-risk PCI (HRPCI) according LV ejection fraction (LVEF). Patients from the PROTECT III study HRPCI were stratified baseline LVEF: severe (LVEF <30%), mild and moderate ≥30% <50%), or preserved function ≥50%). Major adverse cardiovascular cerebrovascular events (MACCE: composite all-cause death,...